| Cat. No. |
Product Name |
Information |
| PC-21437 |
JWH133
CB2 agonist
|
JWH133 (JWH-133) is a potent and selective CB2 agonist with Ki of 3.4 nM, 200-fold selective over CB1 receptors, inhibits glioma growth in vivo. |
| PC-20747 |
LEI-101
CB2R agonist
|
LEI-101 (LEI 101) is a potent, selective, orally available and peripherally restricted cannabinoid CB2 receptor agonist with binding pKi of 7.5 (hCB2R). |
| PC-20746 |
LEI-102
CB2R agonist
|
LEI-102 (LEI 102) is a potent, selective cannabinoid CB2 receptor agonist with binding pKi of 8.0, 1000-fold selectivity over CB1R. |
| PC-20523 |
(±)-Ibipinabant
CB1 antagonist
|
±)-Ibipinabant ((±)-SLV319) is the racemate of SLV319. (±)-Ibipinabant ((±)-SLV319) is a potent and selective cannabinoid-1 (CB-1) receptor antagonist with IC50 of 22 nM. |
| PC-20522 |
Ibipinabant
CB1 antagonist
|
Ibipinabant (SLV319, BMS-646256) is a potent, selective and orally active antagonist of cannabinoid CB1 receptor with Ki of 7.8 nM, >1000-fold selectivity for CB1 over CB2. |
| PC-20521 |
PF-514273
CB1 antagonist
|
PF-514273 (PF 514273) is a potent, selective and orally active antagonist of cannabinoid CB1 receptor with Ki of 1.0 nM, >10000-fold selectivity for CB1 over CB2. |
| PC-20518 |
JD-5006
CB1 antagonist
|
JD-5006 is a potent, selective and peripherally restricted cannabinoid-1 (CB1) receptor blocker with IC50 of 18 nM, does not inhibit CB2 receptor (IC50>5000 nM). |
| PC-61396 |
Revosimeline
|
A novel potent cannabinoid receptor agonist.. |
| PC-42724 |
Otenabant hydrochloride
|
A potent, and selective CB1 receptor antagonist with Ki of 0.7 nM/0.12 nM in binding and functional assays respectively. |
| PC-42066 |
Taranabant (1R,2R) stereoisomer
|
A diastereomer form of Taranabant, which is a potent, selective and orally active cannabinoid-1 receptor (CB1R) inverse agonist. |
